Skip to content

TagDrug & Cosmetic Act

The FDA clears first-ever test to assess risk of developing acute kidney injury.

The US FDA has cleared the NephroCheck test, a first-of-a-kind laboratory test to help determine if critically ill hospitalized patients are at risk of developing moderate to severe acute kidney … Continue Reading The FDA clears first-ever test to assess risk of developing acute kidney injury.

Translate »